Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Immune checkpoint inhibitors as novel targets for renal cell carcinoma therapeutics.

Immune checkpoint inhibitors as novel targets for renal cell carcinoma therapeutics. Cancer J. 2013 Jul-Aug; 19(4):348-52.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.